The national institute for communicable diseases (NICD)
Is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent.
Q: My manager has asked me to re-test before I can return to work even
FOR HEALTHCARE WORKERS-WHAT'S NEW
THE USE OF IVERMECTIN FOR THE TREATMENT OF PREVENTION OF COVID-19Jan 2021
The use of ivermectin for the treatment of prevention of COVID-19 has generated significant global interest. The use of this repurposed medicine is being heavily promoted via social media. However, given the limited evidence of efficacy and safety, as well as appropriate dosing of ivermectin, its place in therapy and prophylaxis remains uncertain at this point.
ANTIGEN TESTING GUIDELINEDec 2020
Whilst PCR testing remains the gold standard for diagnosing SARS-CoV-2 infection, antigen testing provides an important alternative. This document explores the impact of antigen testing for various use cases and guides the implementation of these tests across different settings.
GUIDELINES FOR SYMPTOMS MONITORING AND MANAGEMENT OF ESSENTIAL WORKERS FOR COVID-19 RELATED INFECTIONDEC 2020
The aim of this guideline is to enable early and timeous identification and diagnosis of workers at risk of COVID-19 infection. Another aim is the early referral for appropriate treatment, care and timeous return to work of affected workers.
This guideline provides guidance for developing tender specifications and procuring the required standard and quality of personal protective equipment (PPE), body bags, disinfectants, alcohol-based hand rub (ABHR) and thermometers for use during the COVID-19 pandemic.
POLICY FOR THE REGULATION OF QUALITY RESPIRATORY PROTECTIVE EQUIPMENT SUPPLY IN HEALTHCAREUpdated Oct 2020
The intention of this policy is to ensure that all health workers in South Africa are afforded access to quality respiratory protective equipment, and in particular half face particulate respirators. This translates into best protection against COVID-19 , TB and any other respiratory infectious disease during and post the COVID-19 pandemic.
COVID-19 QUICK REFERENCE FOR HEALTHCARE WORKERSVersion 15 (uploaded 1 Sept 2020)
A quick reference for healthcare workers that summarises the presentation and management of suspected cases, mandatory information to be provided on lab request forms, specimens required for SARS-CoV-2 PCR testing and much more.
LEARN MORE ABOUT COVID-19
Diseases A-Z Index
The disease A-Z index is a directory of diseases that are of public health importance in South Africa, arranged in alphabetical order.
LATEST SCIENTIFIC PUBLICATIONS
The COVID-19 pandemic has been marked by extreme heterogeneity in both geography and population across the world. Consequently, leveraging local data aligned to the unique South African (SA) context is critical.
With the SARS-CoV-2 pandemic passing one million ill people (1 521 252 confirmed cases and 92 798 reported deaths (WHO Sit Rep 10 April), most countries are occupied with controlling the outbreak. The economic consequences are enormous. The World Trade Organization (WTO) estimates that “commerce could shrink up to 32% and warns against 30s-style protectionism” [WTO, 2020]. With no vaccine and no proven effective treatment, the tools available are limited to physical distancing, which includes quarantine and travel restrictions.
A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from a South African patient with coronavirus disease 2019 (COVID-19), who had returned to South Africa after traveling to Italy.